160 related articles for article (PubMed ID: 36621827)
21. Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis.
Schnitzer TJ; Berenbaum F; Conaghan PG; Dworkin RH; Gatti D; Yang R; Viktrup L; Davignon I; West CR; Verburg KM
Rheumatol Ther; 2021 Dec; 8(4):1759-1774. PubMed ID: 34606077
[TBL] [Abstract][Full Text] [Related]
22. Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis.
Kan SL; Li Y; Ning GZ; Yuan ZF; Chen LX; Bi MC; Sun JC; Feng SQ
PLoS One; 2016; 11(6):e0157105. PubMed ID: 27294371
[TBL] [Abstract][Full Text] [Related]
23. Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
Holt RJ; Fort JG; Grahn AY; Kent JD; Bello AE
Phys Sportsmed; 2015 Jul; 43(3):200-12. PubMed ID: 26313454
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
Schnitzer TJ; Ekman EF; Spierings EL; Greenberg HS; Smith MD; Brown MT; West CR; Verburg KM
Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
[TBL] [Abstract][Full Text] [Related]
25. A Two-Step, Trajectory-Focused, Analytics Approach to Attempt Prediction of Analgesic Response in Patients with Moderate-to-Severe Osteoarthritis.
Atkinson J; Edwards RA; Bonfanti G; Barroso J; Schnitzer TJ
Adv Ther; 2023 Jan; 40(1):252-264. PubMed ID: 36301512
[TBL] [Abstract][Full Text] [Related]
26. Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip.
Tive L; Bello AE; Radin D; Schnitzer TJ; Nguyen H; Brown MT; West CR
J Pain Res; 2019; 12():975-995. PubMed ID: 30936738
[TBL] [Abstract][Full Text] [Related]
27. Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis.
Conaghan PG; Abraham L; Viktrup L; Cislo P
BMC Musculoskelet Disord; 2022 Feb; 23(1):106. PubMed ID: 35105318
[TBL] [Abstract][Full Text] [Related]
28. Examining the Relationships Among Treatment, Pain, and Physical Function in Patients With Osteoarthritis: A Mediation-Modeling Approach.
Abraham L; Dworkin RH; Turk DC; Markman JD; Williams DA; Bushmakin AG; Hall JA; Semel DC; Cappelleri JC; Yang R
Clin J Pain; 2023 Apr; 39(4):159-165. PubMed ID: 36806283
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of Various Dosages and Administration Methods of Tanezumab for the Treatment of Pain in Knee and Hip Osteoarthritis: a Network Meta-Analysis.
Cai YZ; Nie LY; Ruan JQ; Zhao K
Clin Ther; 2021 Dec; 43(12):2116-2126. PubMed ID: 34819241
[TBL] [Abstract][Full Text] [Related]
30. Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab.
Carrino JA; McAlindon TE; Schnitzer TJ; Guermazi A; Hochberg MC; Conaghan PG; Brown MT; Burr A; Fountaine RJ; Pixton GC; Viktrup L; Verburg KM; West CR
Osteoarthritis Cartilage; 2023 Dec; 31(12):1612-1626. PubMed ID: 37652258
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials.
Baraf HS; Gloth FM; Barthel HR; Gold MS; Altman RD
Drugs Aging; 2011 Jan; 28(1):27-40. PubMed ID: 21174485
[TBL] [Abstract][Full Text] [Related]
32. Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial.
Watt FE; Blauwet MB; Fakhoury A; Jacobs H; Smulders R; Lane NE
Osteoarthritis Cartilage; 2019 Nov; 27(11):1590-1598. PubMed ID: 31356878
[TBL] [Abstract][Full Text] [Related]
33. Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis.
Brown MT; Cornblath DR; Koltzenburg M; Gorson KC; Hickman A; Pixton GC; Gaitonde P; Viktrup L; West CR
Clin Drug Investig; 2023 Jul; 43(7):551-563. PubMed ID: 37460782
[TBL] [Abstract][Full Text] [Related]
34. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
[TBL] [Abstract][Full Text] [Related]
35. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
36. Huo-Luo-Xiao-Ling (HLXL)-Dan, a Traditional Chinese Medicine, for patients with osteoarthritis of the knee: a multi-site, randomized, double-blind, placebo-controlled phase II clinical trial.
Lao L; Hochberg M; Lee DYW; Gilpin AMK; Fong HHS; Langenberg P; Chen K; Li EK; Tam LS; Berman B
Osteoarthritis Cartilage; 2015 Dec; 23(12):2102-2108. PubMed ID: 26099553
[TBL] [Abstract][Full Text] [Related]
37. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
[TBL] [Abstract][Full Text] [Related]
38. Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab.
Hunter DJ; Schnitzer TJ; Hall J; Semel D; Davignon I; Cappelleri JC; Bushmakin AG; Abraham L
Osteoarthr Cartil Open; 2022 Sep; 4(3):100294. PubMed ID: 36474952
[TBL] [Abstract][Full Text] [Related]
39. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
40. The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Dakin P; DiMartino SJ; Gao H; Maloney J; Kivitz AJ; Schnitzer TJ; Stahl N; Yancopoulos GD; Geba GP
Arthritis Rheumatol; 2019 Nov; 71(11):1824-1834. PubMed ID: 31207169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
